Viewing Study NCT00688493


Ignite Creation Date: 2025-12-25 @ 1:20 AM
Ignite Modification Date: 2025-12-25 @ 11:28 PM
Study NCT ID: NCT00688493
Status: COMPLETED
Last Update Posted: 2012-03-21
First Post: 2008-05-30
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Effects of Single Oral Dose Dapagliflozin QT Study
Sponsor: AstraZeneca
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2007-07
Start Date Type: None
Primary Completion Date: None
Primary Completion Date Type: None
Completion Date: 2008-04
Completion Date Type: ACTUAL
First Submit Date: 2008-05-30
First Submit QC Date: None
Study First Post Date: 2008-06-03
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2012-03-20
Last Update Post Date: 2012-03-21
Last Update Post Date Type: ESTIMATED